7 dead in spreading US meningitis outbreak

October 8, 2012

At least seven people have died and 91 have fallen ill in the United States in a worsening meningitis outbreak tied to a contaminated drug, updated figures showed Sunday.

Cases have been identified in nine states, with the hardest-hit being Tennessee, where 32 people have been diagnosed with the fungal infection and three have died, the said.

Michigan is the second-most infected state, with 20 cases and two deaths, so far. Cases have also been noted in a vast region spanning Florida, Maryland and Minnesota.

In its latest bulletin, the CDC urged doctors to "actively contact" any patients who received doses of the potentially contaminated —typically used to treat back pain—as far back as May 21.

The said symptoms of , which has a very long , include fever, new or worsening headaches, neck stiffness, sensitivity to light, new weakness or numbness, increasing pain, redness or swelling of the injection site.

The —which inflames the protective membranes covering the brain and spinal cord—often goes undetected until it is too late because its flu-like symptoms can be mild at first. But meningitis is not contagious in this form.

Early detection and treatment—requiring a hospital stay to administer intravenous anti-fungal medications—can prevent permanent damage.

An initial investigation found that Tennessee clinicians who administered the contaminated drug "had no way of knowing" there was anything wrong with it and found "no lapses" in their standards, according to the state's health commissioner John Dreyzehner.

"The evidence indicates this is a product issue," he told reporters on Friday.

A multi-state investigation is underway to determine the cause of the outbreak, but the said it had detected a fungal contaminant in a sealed vial of the drug produced by the New England Compounding Center in Massachusetts.

While further testing is required to confirm it was the source of the outbreak, the company has issued a voluntary recall of all of its products and shut down all operations.

Officials posted a list of the 75 health care facilities that received lots of the contaminated drug at: www.cdc.gov/hai/outbreaks/meni … -facilities-map.html

Explore further: US pharmacy linked to outbreak issues wide recall

Related Stories

US pharmacy linked to outbreak issues wide recall

October 7, 2012
(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

US: Avoid drugs from company tied to meningitis (Update)

October 4, 2012
U.S. health officials ramped up warnings Thursday about a specialty pharmacy linked to a widening outbreak of a rare kind of meningitis, urging doctors and hospitals not to use any products from the company.

Rare US fungal meningitis outbreak grows; 5 dead (Update)

October 4, 2012
(AP)—A fifth person has died in a growing outbreak of a rare form of meningitis that has sickened more than two dozen people in five U.S. states.

Steroid-related meningitis cases rise to 47

October 5, 2012
(AP)—As the tally from a deadly meningitis outbreak rose Friday, health officials identified the medical clinics across the country that received steroid shots for back pain now linked to the illnesses.

CDC: More than 90 people ill with meningitis

October 7, 2012
(AP)—Health officials say they have now confirmed more than 90 cases of a rare fungal meningitis that has been linked to a steroid commonly used to ease back pain.

US clinics rush to warn of tainted steroid; 5 dead

October 5, 2012
(AP)—Health providers scrambled to notify patients in nearly two dozen U.S. states that the steroid injections they received for back pain may have been contaminated with a deadly fungal meningitis. Five people have died.

Recommended for you

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Study raises possibility of naturally acquired immunity against Zika virus

November 16, 2017
Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

A structural clue to attacking malaria's 'Achilles heel'

November 16, 2017
Researchers from The Scripps Research Institute (TSRI) and PATH's Malaria Vaccine Initiative (MVI) have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.